Abstract

Metals from IB to IVB groups of the periodic table, because of their flexible oxidation states, natures of coordinated bioligands, and geometries upon complexation, display various properties and efficiency of metal-based cytotoxic drugs. Recent decades have witnessed remarkable progress in the synthesis and therapeutic application of numerous inorganic compounds in cancer investigations. The main potential therapeutic agents, such as the complexes of platinum group metals possessing antineoplastic activity have been broadly described previously in the literature and are beyond the space of this analysis. The key objective of the present study is to analyze the possible activity of IB-IVB group metals their coordination compounds against the cancer cell types. The increasing number of anticancer drug candidates among these metals proves this field offers a remarkably variation of novel opportunities for the synthesis of advanced new pharmaceutics with diverse and specific modes of action. Furthermore, the review provides forthcoming insights into prospective clinical scenarios for approaching treatment applications. That is why this field of research deserves more attention. It is expected that this review can serve as a guiding framework for future investigations in cancer chemotherapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call